Our Most Successful Webcasts
News
Brian Grant Foundation
yesterday
Rytary (carbidopa and levodopa) for Parkinson’s disease
News
Parkinson's News Today – The Web's Daily Resource for Parkinson's News
yesterday
Parkinson’s therapy reduces disease biomarkers in 12-week trial
News
Parkinson's News Today – The Web's Daily Resource for Parkinson's News
yesterday
Speech therapy for Parkinson’s disease
News
Parkinson's News Today – The Web's Daily Resource for Parkinson's News
yesterday
Meditation and breathwork on anxiety in Parkinson's disease: A pilot randomized controlled trial
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
yesterday
GBA1 variants and mortality in Parkinson's disease: A systematic review and meta-analysis
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
Aug. 6, 2026
Psilocybin Therapy for Depression in Parkinson's Disease
Trial
Phase 2
Recruiting
Aug. 6, 2026
User-friendliness of a Portable Driving Simulator
Trial
N/A
Completed
Aug. 6, 2026
Clinical and Physiological Studies of Tremor Syndromes
Trial
N/A
Completed
Aug. 6, 2026
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
Trial
Early Phase 1
Completed
Aug. 6, 2026
Agricultural Health Study Follow-up
Trial
N/A
Completed
Aug. 6, 2026
Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
Trial
N/A
Recruiting
Aug. 6, 2026
Deep Brain Stimulation Therapy in Movement Disorders
Trial
N/A
Recruiting
Aug. 6, 2026
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
Trial
Phase 4
Recruiting
Aug. 6, 2026
Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease
Trial
N/A
Active, not recruiting
Aug. 6, 2026
Blood Pressure Effects on Cognition and Brain Blood Flow in PD
Trial
N/A
Recruiting
Aug. 6, 2026
Deep Brain Stimulation Surgery for Movement Disorders
Trial
N/A
Recruiting
Aug. 6, 2026
Studies of Frontal Lobe Brain Functioning in Schizophrenia
Trial
N/A
Completed
Aug. 6, 2026
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Trial
Phase 2
Recruiting
Aug. 6, 2026
Imaging Biomarkers in Parkinson s Disease
Trial
N/A
Completed
Aug. 6, 2026